Prothena Corp Public PRTA
NASDAQ PRTA
$8.36 -0.18 (-2.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Prothena Corp Public (PRTA) Gains from Sales and Divestitures (2014 - 2026)

Updated

Prothena Corp Public (PRTA) recorded Gains from Sales and Divestitures of -$5,000 in Q2 2026.

Analysis

Prothena Corp Public (PRTA) Gains from Sales and Divestitures (2014 - 2026) Analysis & Trends

On a TTM basis, Prothena Corp Public's Gains from Sales and Divestitures came in at -$107,000 as of Jun 30, 2026; for FY2025, it came in at -$104,000.

  • Across earlier years, Gains from Sales and Divestitures came in at -$15,000 in FY2023 and -$1,000 in FY2022.
  • Quarterly Gains from Sales and Divestitures has ranged from -$101,000 in Q4 2025 to -$1,000 in Q3 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Prothena Corp Public 432.58 Mn -823.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5,000.00
Dec 31, 2025 -101,000.00
Sep 30, 2025 -1,000.00
Mar 31, 2025 -2,000.00
Dec 31, 2018 -483,000.00
Dec 31, 2014 19,000.00
API Access

Prothena Corp Public Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=PRTA&period=max&api_key=YOUR_API_KEY